Detalhe da pesquisa
1.
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
Blood
; 142(10): 903-917, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319434
2.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470365
3.
S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression.
Acta Biochim Biophys Sin (Shanghai)
; 55(2): 194-201, 2023 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810783
4.
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
BMC Med
; 20(1): 108, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379237
5.
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera® ) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial.
Hematol Oncol
; 40(5): 930-940, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858181
6.
Aryl hydrocarbon receptor signaling pathway plays important roles in the proliferative and metabolic properties of bone marrow mesenchymal stromal cells.
Acta Biochim Biophys Sin (Shanghai)
; 53(11): 1428-1439, 2021 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508548
7.
AHR signaling pathway reshapes the metabolism of AML/MDS cells and potentially leads to cytarabine resistance.
Acta Biochim Biophys Sin (Shanghai)
; 53(4): 492-500, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709099
8.
A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety With Therapeutic Drug Monitoring.
Clin Infect Dis
; 67(suppl_2): S249-S255, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423040
9.
Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients.
Clin Infect Dis
; 67(suppl_2): S256-S262, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423042
10.
Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.
J Transl Med
; 16(1): 234, 2018 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143008
11.
TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.
Br J Haematol
; 176(4): 600-608, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984642
12.
Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers.
Proc Natl Acad Sci U S A
; 111(23): 8589-94, 2014 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850867
13.
High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.
J Transl Med
; 14: 66, 2016 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944860
14.
Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes.
Tumour Biol
; 37(4): 4633-40, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508027
15.
NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy.
Br J Haematol
; 189(5): 982-984, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266961
16.
Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
Haematologica
; 100(2): 194-204, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361944
17.
Impaired osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with lower-risk myelodysplastic syndromes.
Tumour Biol
; 35(5): 4307-16, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443267
18.
High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome.
Tumour Biol
; 35(3): 2211-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142530
19.
Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Eur J Haematol
; 93(6): 476-86, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24889123
20.
Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.
Leuk Lymphoma
; 65(1): 100-108, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865969